The goals of this project are to characterize the molecular mechanisms by which cowpox virus (CPXV) and monkeypox virus (MPXV) inhibit T cell stimulation and the impact of these immune evasion mechanisms on viral virulence and the development of anti-viral immune responses. We previously demonstrated that CPXV inhibits MHC-l-mediated antigen presentation thus escaping poxvirus-specific CD8+ T cells. Preliminary data suggest that, in addition, CPXV escapes CD4+ T cell stimulation and inactivates T cells in trans, i.e. without infecting T cells and independent of antigen presentation. The latter mode of T cell inhibition is very similar to our previously reported mechanism by which MPXV inhibits MHC-independent T cell stimulation. We therefore hypothesize that the responsible gene products are conserved between CPXV and MPXV. By analyzing deletion mutants we identified a gene region in the CPXV genome encoding the genes responsible for both CD4+ T cell escape and inhibiting T cell stimulation by anti-CD3. Since both antigen-dependent-and antigen-independent stimulation of T cells requires signal-transduction by the T cell receptor (TCR), it is conceivable that a single gene is responsible for both T cell evasion phenotypes. In three specific aims, we will (I) identify the genes in CPXV and MPXV responsible for inhibiting MHC-l-independent T cell stimulation by CPXV and MPXV, (II) characterize the corresponding gene products of CPXV and MPXV and determine how they inhibit TCR-mediated T cell activation, and (111) examine the role of T cell evasion for CPXV virulence and the impact of these inhibitory mechanisms on the development of antiviral immune responses in vivo: Since T cell inactivation by CPXV and MPXV is unlike any other viral T cell inhibitor mechanism described to date, our studies are expected to uncover novel molecular strategies for viral immune evasion. We further expect that this work will lead to a re-evaluation of the role of T cell evasion in the pathogenesis of zoonotic orthopoxviruses (and potentially smallpox, if the T cell inhibitors are conserved in Variola major) because these evasion mechanisms are absent from the widely studied Vaccinia Virus (W) and the mousepox virus ectromelia (ECTV).
T lymphocytes are central to our immune defense against viruses, yet many viruses developed clever strategies to overcome T cell immunity. While in most cases viruses hide from T cells by preventing infected cells from presenting viral antigen to T cells, we now show that some poxviruses, including those causing smallpox and monkeypox, instead encode a protein that renders T cells non-responsive.
|Loo, Christopher P; Nelson, Nicholas A; Lane, Ryan S et al. (2017) Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection. Cell Rep 20:3176-3187|
|Ghasemi, Reza; Lazear, Eric; Wang, Xiaoli et al. (2016) Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy. Nat Commun 7:12878|
|Gilchuk, Iuliia; Gilchuk, Pavlo; Sapparapu, Gopal et al. (2016) Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections. Cell 167:684-694.e9|
|Lubman, Olga Y; Fremont, Daved H (2016) Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors. Structure 24:57-69|
|Nelson, Christopher A; Epperson, Megan L; Singh, Sukrit et al. (2015) Structural Conservation and Functional Diversity of the Poxvirus Immune Evasion (PIE) Domain Superfamily. Viruses 7:4878-98|
|Nelson, Christopher A; Lee, Chung A; Fremont, Daved H (2014) Oxidative refolding from inclusion bodies. Methods Mol Biol 1140:145-57|
|Alzhanova, Dina; Hammarlund, Erika; Reed, Jason et al. (2014) T cell inactivation by poxviral B22 family proteins increases viral virulence. PLoS Pathog 10:e1004123|
|Nelson, Christopher A; McCoy, William H; Fremont, Daved H (2014) Eukaryotic expression systems for structural studies. Methods Mol Biol 1140:107-16|
|Luteijn, Rutger D; Hoelen, Hanneke; Kruse, Elisabeth et al. (2014) Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J Immunol 193:1578-89|